Aerie Pharmaceuticals Inc AERI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/06/22 EDT
8.27quote price arrow up+8.27 (UNCH)
Volume
5,802
Close
8.27quote price arrow down-0.21 (-2.48%)
Volume
405,544
52 week range
4.81 - 17.21
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.27
  • 52 Week High17.21
  • 52 Week High Date09/13/21
  • 52 Week Low4.81
  • 52 Week Low Date06/02/22

Key Stats

  • Market Cap402.09M
  • Shares Out48.62M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change17.81

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.27
  • 52 Week High17.21
  • 52 Week High Date09/13/21
  • 52 Week Low4.81
  • 52 Week Low Date06/02/22
  • Market Cap402.09M
  • Shares Out48.62M
  • 10 Day Average Volume0.77M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change17.81

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-5.61
  • Fwd P/E (NTM)-5.56
  • EBITDA (TTM)-39.274M
  • ROE (TTM)-2,255.01%
  • Revenue (TTM)201.00M
  • Gross Margin (TTM)86.60%
  • Net Margin (TTM)-34.20%
  • Debt To Equity (MRQ)-247.93%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aerie Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aerie Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions, including open-angle glaucoma, dry eye, diabetic macular edema (DME) and wet age-related macular degeneration (wet AMD). The Company's commercial products include Rhopressa and Rocklatan. Rhopressa is a once-daily eye drop designed to reduce elevated...
Raj Kannan
Chief Executive Officer, Director
Peter Lang
Chief Financial Officer
John Larocca Esq., J.D.
General Counsel and Secretary
Address
4301 Emperor Boulevard, Suite 400
Durham, NC
27703
United States

Top Peers

SYMBOLLASTCHG%CHG
ESPR
Esperion Therapeutics Inc
6.69-0.30-4.29%
OMER
Omeros Corp
3.58+0.49+15.86%
OPTN
OptiNose Inc
3.81UNCHUNCH
CSTL
Castle Biosciences Inc
23.34-0.97-3.99%
ASRT
Assertio Holdings Inc
3.18-0.09-2.75%